Preparation and physicochemical characterization of N-succinyl chitosan-coated liposomes for oral delivery of grape seed extract and evaluation of its effect on pulmonary fibrosis induced by bleomycin in rats

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 65

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-26-10_015

تاریخ نمایه سازی: 4 شهریور 1402

Abstract:

Objective(s): This study aimed to develop an oral succinyl chitosan-coated liposomal formulation containing grape seed extract and assess its therapeutic efficacy in rats with bleomycin-induced pulmonary fibrosis. Materials and Methods: N-succinyl chitosan was synthesized, and the liposomal formulations were prepared and characterized regarding phenolic content assay and morphology. Size, zeta potential, in vitro drug release, and stability. Pulmonary fibrosis was induced by intratracheal bleomycin injection, and hydroxyproline measurements, lung weight, animal body weight, as well as histopathological studies were performedResults: Succinyl chitosan increases the physical stability of the formulation, especially in acidic conditions. Drug release studies revealed that ۶۶.۲۷% of the loaded drug was released from CF۲ in an acidic medium in ۲ hr, but ۹۲.۳۱% of the drug was released in ۸ hr in a pH=۷ medium. An in vivo study demonstrated that rats exposed to bleomycin significantly lost weight, while those treated with CF۲ (۴۰۰ mg/kg) partially regained weight. Bleomycin treatment increased the mean lung weight and the amount of hydroxyproline in the lungs; these values were significantly decreased in the group treated with ۴۰۰ mg/kg CF۲ (P<۰.۰۵). Histopathological examination confirmed that treatment with ۴۰۰ mg/kg CF۲ improved lung fibrosis. Conclusion: In rats, oral administration of N-succinyl chitosan-coated liposomes containing grape seed extract at the ۴۰۰ mg/kg dose ameliorates bleomycin-induced pulmonary fibrosis.

Authors

Neda Bavarsad

Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Aliasghar Hemmati

Department of Pharmacology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Fateme Jafarian

Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Azar Mostoufi

Marine Pharmaceutical Science Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Amir Siahpoosh

Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Mohammadreza Rashidi Nooshabadi

Department of Pharmacology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Esrafil Mansouri

Cellular and Molecular Research Center, Department of Anatomical Sciences, Faculty of Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Merkt W, Bueno M, Mora AL, Lagares D. Senotherapeutics: Targeting ...
  • Sgalla G, Biffi A, Richeldi L. Idiopathic pulmonary fibrosis: Diagnosis, ...
  • Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, ...
  • Mansouri MT, Rajabi Vardanjani H, Hemmati AA, Reza Tabandeh M, ...
  • Gomer RH, Lupher Jr ML. Investigational approaches to therapies for ...
  • Sgalla G, Franciosa C, Simonetti J, Richeldi L. Pamrevlumab for ...
  • Abidi A, Kourda N, Feki M, Ben Khamsa S. Protective ...
  • Melo AC, Patil P, Gallagher P, Tallant E. A polyphenol ...
  • Castangia I, Marongiu F, Manca ML, Pompei R, Angius F, ...
  • Farzan M, Québatte G, Strittmatter K, Hilty FM, Schoelkopf J, ...
  • Manconi M, Marongiu F, Castangia I, Manca ML, Caddeo C, ...
  • He H, Lu Y, Qi J, Zhu Q, Chen Z, ...
  • Lang X, Wang T, Sun M, Chen X, Liu Y. ...
  • Prabaharan M, Mano JF. Chitosan-based particles as controlled drug delivery ...
  • Caddeo C, Pons R, Carbone C, Fernàndez-Busquets X, Cardia MC, ...
  • Bavarsad N, Hemmati G, Ataee S, Sistani Karampour N. Preparation ...
  • Nikbakht J, Hemmati AA, Arzi A, Mansouri MT, Rezaie A, ...
  • Raish M, Ahmad A, Ahmad Ansari M, Ahad A, Al-Jenoobi ...
  • Farhadihosseinabadi B, Gholipourmalekabadi M, Salimi M, Abdollahifar M-A, Bagheri M, ...
  • Manafi Dizajyekan M, Hadad Khodaparast MH, Azadmard-Damirchi S, Valizadeh H, ...
  • Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: In ...
  • Tahara K, Nishio M, Takeuchi H. Evaluation of liposomal behavior ...
  • Manconi M, Nácher A, Merino V, Merino-Sanjuan M, Manca ML, ...
  • Terao J, Piskula M, Yao Q. Protective effect of epicatechin, ...
  • Javadi I, Rashidi Nooshabadi M, Goudarzi M, Roudbari R. Protective ...
  • نمایش کامل مراجع